Research Article

Synthesis and stability analysis of folic acid-graphene oxide nanoparticles for drug delivery and targeted cancer therapies

Volume: 3 Number: 2 August 15, 2019
EN

Synthesis and stability analysis of folic acid-graphene oxide nanoparticles for drug delivery and targeted cancer therapies

Abstract

Cancer is the growth and proliferation of damage-ending cells in an uncontrolled or abnormal way. Today, it takes place among the most important health problems around the world and in our country. Surgery, radiotherapy, and chemotherapy are the main treatment methods in cancer treatment. The development of resistance to chemotherapeutic medicines has led scientists to investigate this issue as well as the drug’s ability to reach the targeted tumor site and destroying cancer cells in addition to normal cells. The production of various nanostructures for anticancer drug development has been one of the most important areas of nanomedicine. Thus, in the present research, the improved Hummers’ method was employed for the synthesis of graphene oxide nanoparticle (NGO), and it was activated by the folic acid (FA) antibody to increase targeting ability after attachment of the drug to the nanostructure systems. SEM, FTIR, XRD, UV/Vis spectroscopy, and zeta potential analysis were performed for characterization of the products. The highest absorbance of the FA-NGO/DIW nanostructures produced at the concentration of 0.01 mg/ml-0.05 mg/ml synthesized by the Hummers’ method and in the UV/Vis spectra, peaks at 232 nm and 270 nm corresponds to NGO-DIW and FA-NGO/DIW, respectively. The zeta potential value above 35 mV was obtained in all measurements, and the NGO-DIW and NGO-FA-DIW samples maintained stability for days. These findings are consistent with the few studies in the literature, and this study will guide future studies in which nanoparticle systems will be directed to the target by binding chemotherapeutic drugs. 

Keywords

References

  1. 1. Warheit, D. B., Sayes, C. M., Reed, K. L., & Swain, K. A. Health effects related to nanoparticle exposures: environmental, health and safety considerations for assessing hazards and risks. Pharmacology & therapeutics, 2008, 120 (1), 35-42.
  2. 2. Gonzalez, L., Lison, D., & Kirsch-Volders, M. Genotoxicity of engineered nanomaterials: a critical review. Nanotoxicology, 2008, 2(4), 252-273.
  3. 3. Geim, Andre K., and Konstantin S. Novoselov. The rise of graphene, Nature materials, 2007, 6.3, 183.
  4. 4. Neto, A. C., Guinea, F., Peres, N. M., Novoselov, K. S., & Geim, A. K. The electronic properties of graphene. Reviews of modern physics, 2009, 81(1), 109.
  5. 5. Becerril, H. A., Mao, J., Liu, Z., Stoltenberg, R. M., Bao, Z., & Chen, Y. Evaluation of solution-processed reduced graphene oxide films as transparent conductors. ACS nano, 2008, 2(3), 463-470.
  6. 6. Stankovich, S., Dikin, D. A., Dommett, G. H., Kohlhaas, K. M., Zimney, E. J., Stach, E. A., ... & Ruoff, R. S. Graphene-based composite materials. nature, 2006, 442(7100), 282.
  7. 7. Wang, C., Li, D., Too, C. O., & Wallace, G. G. Electrochemical properties of graphene paper electrodes used in lithium batteries. Chemistry of Materials, 2009, 21(13), 2604-2606.
  8. 8. Pasricha, R., Gupta, S., & Srivastava, A. K. A Facile and Novel Synthesis of Ag–Graphene‐Based Nanocomposites. Small, 2009, 5(20), 2253-2259.

Details

Primary Language

English

Subjects

-

Journal Section

Research Article

Publication Date

August 15, 2019

Submission Date

April 2, 2018

Acceptance Date

September 10, 2018

Published in Issue

Year 2019 Volume: 3 Number: 2

APA
Keklikcioğlu Çakmak, N., Küçükyazıcı, M., & Eroğlu, A. (2019). Synthesis and stability analysis of folic acid-graphene oxide nanoparticles for drug delivery and targeted cancer therapies. International Advanced Researches and Engineering Journal, 3(2), 81-85. https://doi.org/10.35860/iarej.411717
AMA
1.Keklikcioğlu Çakmak N, Küçükyazıcı M, Eroğlu A. Synthesis and stability analysis of folic acid-graphene oxide nanoparticles for drug delivery and targeted cancer therapies. Int. Adv. Res. Eng. J. 2019;3(2):81-85. doi:10.35860/iarej.411717
Chicago
Keklikcioğlu Çakmak, Neşe, Mustafa Küçükyazıcı, and Atakan Eroğlu. 2019. “Synthesis and Stability Analysis of Folic Acid-Graphene Oxide Nanoparticles for Drug Delivery and Targeted Cancer Therapies”. International Advanced Researches and Engineering Journal 3 (2): 81-85. https://doi.org/10.35860/iarej.411717.
EndNote
Keklikcioğlu Çakmak N, Küçükyazıcı M, Eroğlu A (August 1, 2019) Synthesis and stability analysis of folic acid-graphene oxide nanoparticles for drug delivery and targeted cancer therapies. International Advanced Researches and Engineering Journal 3 2 81–85.
IEEE
[1]N. Keklikcioğlu Çakmak, M. Küçükyazıcı, and A. Eroğlu, “Synthesis and stability analysis of folic acid-graphene oxide nanoparticles for drug delivery and targeted cancer therapies”, Int. Adv. Res. Eng. J., vol. 3, no. 2, pp. 81–85, Aug. 2019, doi: 10.35860/iarej.411717.
ISNAD
Keklikcioğlu Çakmak, Neşe - Küçükyazıcı, Mustafa - Eroğlu, Atakan. “Synthesis and Stability Analysis of Folic Acid-Graphene Oxide Nanoparticles for Drug Delivery and Targeted Cancer Therapies”. International Advanced Researches and Engineering Journal 3/2 (August 1, 2019): 81-85. https://doi.org/10.35860/iarej.411717.
JAMA
1.Keklikcioğlu Çakmak N, Küçükyazıcı M, Eroğlu A. Synthesis and stability analysis of folic acid-graphene oxide nanoparticles for drug delivery and targeted cancer therapies. Int. Adv. Res. Eng. J. 2019;3:81–85.
MLA
Keklikcioğlu Çakmak, Neşe, et al. “Synthesis and Stability Analysis of Folic Acid-Graphene Oxide Nanoparticles for Drug Delivery and Targeted Cancer Therapies”. International Advanced Researches and Engineering Journal, vol. 3, no. 2, Aug. 2019, pp. 81-85, doi:10.35860/iarej.411717.
Vancouver
1.Neşe Keklikcioğlu Çakmak, Mustafa Küçükyazıcı, Atakan Eroğlu. Synthesis and stability analysis of folic acid-graphene oxide nanoparticles for drug delivery and targeted cancer therapies. Int. Adv. Res. Eng. J. 2019 Aug. 1;3(2):81-5. doi:10.35860/iarej.411717

Cited By



Creative Commons License

Any further distribution of this work must maintain attribution to the author(s) and the title of the work, journal citation and DOI.